No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Zarontin (ethosuximide) is a medication used to treat certain types of seizures in people with epilepsy. It is a central nervous system (CNS) drug, and is classified as an anticonvulsant. Zarontin works by decreasing the abnormal electrical activity in the brain that causes seizures. It is usually taken twice a day, with or without food.
The Zarontin market is a subset of the larger CNS drug market. It is composed of generic and branded versions of the drug, as well as other anticonvulsants. The market is highly competitive, with many companies vying for market share.
Some of the companies in the Zarontin market include Pfizer, GlaxoSmithKline, Novartis, Mylan, and Teva Pharmaceuticals. Show Less Read more
